About Us

A mission to make a difference in people’s lives

IBRI is dedicated to advancing science that contributes directly to the improvement of human health. We create not only knowledge, but the tools, technology, and talent to turn new scientific discoveries into breakthrough treatments for serious diseases.

Alan Palkowitz, Ph.D. Alan Palkowitz, Ph.D. President and CEO
Michele Sawyer, CPA Michele Sawyer, CPA Chief Financial Officer & Executive Vice President of Project Management
Amy DeFelice Amy DeFelice Executive Vice President of Human Resources & Enterprise Systems
Ari Landon, PhD Ari Landon, PhD Chief Business Development Officer
Christopher Conway Christopher Conway Executive Vice President of Communications & Chief Philanthropy Officer
Christina Bodurow, Ph.D. Christina Bodurow, Ph.D. Senior Vice President of Project Management
Will Lawson, JD Will Lawson, JD Vice President and General Counsel
Louis Stancato, PhD Louis Stancato, PhD Vice President of Enabling Technologies and Global Leader of Pediatric Rare Disease Platform
Patrick Knerr, PhD Patrick Knerr, PhD Vice President, Metabolic Translational Research & Peptide Innovation
Nansa Amarsaikhan Staff Scientist I
Erica P. Cai Scientific Director
Jonathan Crawford Staff Scientist I
Elizabeth Delery, PhD Staff Scientist II
Jonathan Douros Senior Scientific Director
Francis O. Enane, PhD Staff Scientist III
Anna Geisinger Researcher III
Joe Jakubowski Senior Scientific Director
June Javens-Wolfe Researcher IV
Mike Kalwat Scientific Director
Becky Klein Director
Joshua Kulas Staff Scientist II
Debjyoti Kundu Postdoctoral Fellow
Peter Lander Senior Scientific Director
Olivia Lazaro Researcher I, Biostatistics
Kyu Been Lee Researcher II
Emma K. Lendy, PhD Staff Scientist I
Sydney Leohr Researcher I
Tanasha Lertjanyarak Researcher II
Hope Liechty Researcher II
Betty Lorentz Researcher I
Connor A. Mahler Researcher II
Roberto Mallone Senior Scientific Director
Mustapha Moussaif Staff Scientist III
Stephanie Mowery Staff Scientist III
Raymond Muller Vice President
Jason Myers Senior Director
Andrea Ordonez Researcher I
Deep Patel Researcher II
Mariya Raleigh Researcher II
Sylvia Robertson Researcher II
Michael Robo Staff Scientist II
Kobe Rogers Director
Gitanjali Roy Researcher II
Tom Ryder Researcher II
Mackenzie M. Spicer Rysted, Ph.D. Postdoctoral Fellow
Lilia (Lily) Sanchez Postdoctoral Fellow
Rashmi Shrinivasan Researcher II
Jake Smiley Researcher I
Abdul Qadir Syed Scientific Director
Matthew Valli Staff Scientist III
Chialing Wu Researcher IV
Kazuhiro Yamada Staff Scientist II
Sylvaine You Senior Scientific Director
Daniel Evans, Jr. Former Chief Executive Officer, Indiana University Health
Tatiana Foroud, PhD Executive Associate Dean for Research Affairs, Indiana University School of Medicine
Daniel Golden Vice President & Global Head of Research, Discovery & Breakthrough Innovation, Elanco Animal Health
Michael Harrington Former Senior Vice President and General Counsel, Eli Lilly and Company
Lisa Hershman Indiana Secretary of Management and Budget
Jay Hess, MD, PhD, MHSA Executive Vice President for University Clinical Affairs, Indiana University
David Ingram, MD Chief Medical Executive and Executive Vice President, Indiana University Health
John Lechleiter, PhD Former Chairman, President, and Chief Executive Officer, Eli Lilly and Company
Debra Luffer-Atlas, PhD Senior Vice President of Research, Eli Lilly and Company
Russell J. Mumper Vice President for Research, Indiana University
Alan D. Palkowitz, PhD President and CEO, IBRI
Dan Peterson Vice President, Industry and Government Affairs, Cook Group Inc.
Jeffrey F. Rhoads, PhD Vice President for Research, University of Notre Dame
Preeti Sivasankar, PhD Vice President for Research Innovation, Purdue University
Aaron Schacht Chief Executive Officer, BiomEdit, LLC
Wendy Srnic, PhD Vice President of Biotechnology, Corteva Agriscience
Kaye Vitug Senior Vice President and Chief Financial Officer, Roche Diagnostics North America
Vince Wong President and CEO, BioCrossroads

Founders

BioCrossroads
Cook Medical
Corteva Agriscience
Eli Lilly & Company Foundation
Indiana University Health
Indiana University School of Medicine
Lilly Endowment
Roche Diagnostics
State of Indiana

Our rich innovation ecosystem

IBRI’s location puts it at a nexus of top research universities and hospitals, entrepreneurial biotechnology startups, and premier pharmaceutical companies.

Through cross-sector collaboration with organizations such as the Indiana University School of Medicine, Indiana University, Purdue University, IU Health, and Eli Lilly and Company, we advance science, generate economic growth, create high-value jobs, and foster a new generation of biotech pioneers.